Roger Reddel

Chae-Ok Yun
"Adenovirus/Nanomaterial Complex for Cancer Gene Therapy"

Position

Professor
Department of Bioengineering
School of Engineering
Hanyang University Korea

Profile

Chae-Ok Yun is currently a Professor of Bioengineering at Hanyang University, Seoul, Korea. She is also an Adjunct Professor of Pharmaceuticals and Pharmaceutical Chemistry at University of Utah, Salt Lake City, United States, an Affiliate Professor of Medicine at University of Washington, United States, and an Adjunct Professor of Genomics at Yonsei University. She received her BS (1986) and MS (1988) degree in Molecular Biology from Sogang University, Seoul, Korea. In 1996, she received Ph.D. degree in Molecular and Cellular Biology from Illinois Institute of Technology, Chicago, United States.

From 1996 to 1998, she completed a postdoctoral fellowship in Hematology and Oncology at Harvard Medical School, Boston, and then served as a Research Associate in Radiation Oncology at Harvard Medical School, Boston, until 2000. She next moved back to Seoul, Korea where she was firstly Assistant Professor (2000), Associate Professor (2005), Professor (2010) at Yonsei University College of Medicine, and then Professor (2011) at Hanyang University.

She has served as Deputy Editor of Molecular Therapy (2010-), Associate Editor of BMC Cancer (2010-), Associate Editor of Cancer Gene Therapy (2013-), Editorial Board member of Journal of Controlled Release (2010-), Distinguished member of international advisory board of the Gene Therapy and Regulation (2010-), Honorary Editorial Board member of Oncolytic Virotherapy (2012-) and Editorial Board member of International Journal of Cancer Research & Diagnosis (2013-). She also serves University of Utah (2010-) in United States, University of Seattle in United States (2012-), and Sichuan University in China (2013-) as an Adjunct Professor.

She was awarded the Excellence in Research Award from American Society of Gene Therapy in 2002 and Excellent Professor in Research Achievement from Yonsei University in 2003, 2005, 2007, 2008, and 2011. She received the Bowon Award for Best Research Activity from Yonsei University in 2007. She also was awarded the Excellence in Research Award from Korean Society of Gene Therapy (2011 & 2012) and Korean Government Ministry award from Ministry of Science (2013).

Her research interests include cancer gene therapy, immunotherapy, angiogenesis, combination of viral vectors and non-viral vectors, nanomedicine, and tumor biology. One of her gene therapeutics is in clinical trial against cancer patients.

EDITOR, EDITORIAL & ADVISORY BOARD

  • Molecular Therapy, Deputy Editor (2010-)
  • BMC Cancer, Associate Editor (2010-)
  • Gene Therapy and Regulation, Distinguished Member of International Advisory Board (2010-)
  • Journal of Controlled Release, Editorial Board Member (2010-)
  • Oncolytic Virotherapy, Honorary Editorial Board Member (2012-)
  • Oxford Centre for Drug Delivery Devices, International Advisory Board Member (2013-)
  • Cancer Gene Therapy, Associate Editor (2013-)
  • Int J of Cancer Research & Diagnosis, Editorial Board Member (2013-)